- Home
- / Capricor Therapeutics
- / Financials
Capricor TherapeuticsHeader placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Financial statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.4M | 195.5K | 503.2K | 4.8M | 5.5M | 4.0M | 2.7M | 1.7M | 1.0M | 310.3K | 244.9K |
| Revenue growth, % | 851.2% | 15.3% | -27.5% | ||||||||
| General and administrative expense | 2.1M | 1.6M | 2.2M | 3.0M | 4.4M | 4.9M | 4.8M | 4.9M | 3.6M | 5.5M | 7.6M |
| Operating expense total | 6.3M | 2.6M | 7.4M | 10.8M | 18.1M | 21.0M | 15.5M | 17.0M | 8.7M | 14.0M | |
| EBIT | (4.9M) | (2.4M) | (6.9M) | (6.0M) | (12.6M) | (17.0M) | (12.9M) | (15.3M) | (7.7M) | (13.7M) | (20.9M) |
| EBIT margin, % | -361.7% | -1248.2% | -1371.7% | -125.7% | -228.6% | -424.6% | -482.4% | -917.0% | -769.5% | -4412.6% | |
| Interest income | 6.0K | 1.2K | 1.9K | 3.1K | 14.4K | 38.5K | 136.0K | 94.8K | 32.9K | 57.5K | |
| Interest expense | 14.4K | 58.1K | 245.5K | 1.8M | 15.3M | ||||||
| Net Income | (4.9M) | (1.9M) | (8.9M) | (6.2M) | (12.9M) | (18.8M) | 2.4M | (15.2M) | (7.6M) | (13.7M) | (20.0M) |